CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

adriano mollica - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

adriano mollica

OPENALEX: A5016876491↗ORCID: 0000-0002-7242-4860↗

Affiliations

Organizations

University of Chieti-Pescaraauthorship · IT

Public evidence

3 connected articles

Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands.2023 · Europe PMC Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity.2019 · Europe PMC Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.2017 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.